Proactive Investors - Run By Investors For Investors

Alchemist Mining updates on Island Therapeutics deal, aimed at producing new remedies

British Columbia-based Island Genetics is focused on research and development (R&D) within the cannabis industry
Inking a deal
Alchemist has signed a binding letter of intent to enter into the agreement with IG

Alchemist Mining Inc (CSE:AMS) has inked a deal to take a stake in Island Therapeutics in bid to develop new strains of cannabis, targeting specific ailments.

British Columbia-based Island Genetics is focused on research and development (R&D) within the cannabis industry and the production and preservation of exotic heirlooms, unique hybrids, as well as other cannabis strains.

READ: Alchemist Mining takes 15% stake in Island Therapeutics

The company began in 2013 as a research project for Davis Allen to treat his chronic stomach disorder.

To get  the 15% stake, Alchemist said it would complete a share exchange, valued at C$112,500.

"Having recently announced a partnership to deliver transdermal cannabis patch technology, it was the natural next step to partner with a group like Island Genetics that is targeting specific ailments and researching and developing the best of breed cannabis strains to address them", said Alchemist CEO, Paul Mann.

The aim of  the agreement is to commercialize the existing genetics library of IG and further develop new strains of cannabis, targeting specific ailments.

Davis Allen, Founder of Island Genetics, added: "We look forward to working with Paul and his team at Alchemist because we truly believe the products that he is working on will have a powerful impact on the cannabis industry. We also admire Paul's professionalism and by-the-book approach- which is less common in this industry than people think. This has given us the confidence to take this step with Alchemist and become a partner."

View full AMS profile View Profile

Alchemist Inc Timeline

Related Articles

immotion vr racing game
February 06 2019
The out-of-home VR hardware and content maker turned over more than £1mln in the second half of 2018 with ‘only’ 150 or so headsets in operation, but it wants that figure to climb to over 1,000 by the end of this year
ROBO Global US CEO Travis Briggs
August 15 2018
Investors can buy directly into the popular ROBO ETF based on the benchmark index comprised of 87 top robotics, automation and AI companies.
Tavistock
May 29 2019
"We aim to continue to improve the group's profitability and manage a regular and growing dividend stream for the benefit of our shareholders," said CEO Brian Raven

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use